Formulation Development For Injectables With Captisol®

Poor solubility is a major challenge for drug sponsors, as the development process is often stalled due to a drug candidate's low aqueous solubility, leading to difficulties in formulation and reduced bioavailability. A uniquely modified cyclodextrin is emerging as a versatile and indispensable tool in the formulation and development process as it significantly improves solubility, stability, bioavailability, and dosing of active pharmaceutical ingredients (APIs).

Capistol's molecular structure enhances drug molecules’ solubility in aqueous solutions, allowing for the development of more effective drug product presentations. Its ability to encapsulate the drug molecule enhances stability and enables the development of long-lasting and reliable drug products, and the enhanced bioavailability ensures a more predictable and effective therapeutic response. Explore the benefits of improved and reliable drug formulations and how the right approach can enhance drug delivery and improve patient outcomes.